Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
WSE.US
id: 2166

Wise Group (WSE) AML Compliance Deficiencies Case

Attorneys review the case details to decide whether to proceed with a class action.
S.D. New York
Court
1:26-cv-06582
Case number
05/11/2026
Class period Start
07/23/2026
Class period End
09/29/2026
Lead Plaintiff motion deadline
  • $WSE stockholder filed a claim against Wise Group for touting its NASDAQ debut and downplaying regulatory risk while concealing that it was under active Belgian money-laundering investigation and had "longstanding" deficiencies in its anti-money laundering and counter-terrorism financing controls that jeopardized its pending U.S. national bank charter application.
  • After Reuters revealed a Belgian prosecutor's investigation into more than half a billion euros in suspicious transactions tied to Wise, followed weeks later by the U.S. OCC's denial of Wise's national trust bank license over "longstanding" AML deficiencies, $WSE fell a combined 20.4% across the disclosures.
  • $WSE investors can join this case to be notified about potential recovery.
Case Details:

On May 11, 2026, coinciding with its primary listing move to the NASDAQ, Wise filed a Registration Statement describing its regulatory risks in general, hypothetical terms, characterizing potential AML and counter-terrorism financing compliance failures as future possibilities while noting it had applied for a U.S. national trust bank charter.

However, investors allege Wise omitted that it was already under active investigation by Belgian authorities and had a present, "longstanding" deficiency in its AML and anti-terror financing controls, which the company knew or should have known jeopardized its regulatory standing and its pending bank charter application.

Then, on June 1, 2026, Reuters reported that Belgian prosecutors were investigating Wise's European entity over more than half a billion euros in suspicious transactions, with alleged links to fraud, corruption, and drug trafficking.

On this news, $WSE fell 5.2% to $12.10, then continued falling over the following two trading days to $10.72, a decline of roughly 15.6% across three sessions.

Additional developments followed on July 24, 2026, when the Wall Street Journal reported that the OCC had denied Wise's national trust bank license application, citing "long-standing deficiencies" in its anti-money laundering and counter-terrorism financing program.

On this news, $WSE fell a further 6.2%, closing at $11.33.

Based on these events, $WSE investors filed a claim against Wise Group, alleging the company:
  • It understated its regulatory risk despite being under active investigation by Belgian authorities.
  • It hid longstanding, material deficiencies in its anti-money laundering and counter-terrorism financing controls.
  • It caused investor losses when both the Belgian investigation and the U.S. bank charter denial revealed the true scope of its compliance failures.
Investors argue Wise Group misled the market about the adequacy of its anti-money laundering controls, causing losses when regulatory scrutiny in both Europe and the U.S. revealed the truth.
Case Type
US Securities Class Action
Case Status
Attorney Investigation
Alleged Offence
Misleading Statements
Failure to Disclose
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
07/24/2026
Filing date
07/31/2026
Lead Plaintiff Deadline
09/29/2026